Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Elisabetta Patorno, Dr.P.H., M.D.

Co-Author

This page shows the publications co-authored by Elisabetta Patorno and Rishi Desai.
Connection Strength

4.673
  1. Epidemiologic Characterization of Heart Failure with Reduced or Preserved Ejection Fraction Populations Identified Using Medicare Claims. Am J Med. 2021 04; 134(4):e241-e251.
    View in: PubMed
    Score: 0.876
  2. Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All-Cause or Cardiovascular Mortality Using Administrative Claims. J Am Heart Assoc. 2020 09; 9(17):e016906.
    View in: PubMed
    Score: 0.866
  3. Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care. Heart. 2021 09; 107(17):1407-1416.
    View in: PubMed
    Score: 0.228
  4. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLoS Med. 2020 09; 17(9):e1003322.
    View in: PubMed
    Score: 0.217
  5. Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model. Clin Epidemiol. 2020; 12:607-616.
    View in: PubMed
    Score: 0.214
  6. Development and Preliminary Validation of a Medicare Claims-Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure. Circ Cardiovasc Qual Outcomes. 2018 12; 11(12):e004700.
    View in: PubMed
    Score: 0.192
  7. Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome. Pharmacoepidemiol Drug Saf. 2018 Dec; 27(12):1361-1370.
    View in: PubMed
    Score: 0.191
  8. Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study. Neurology. 2018 01 23; 90(4):e342-e351.
    View in: PubMed
    Score: 0.180
  9. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ. 2017 Aug 02; 358:j3326.
    View in: PubMed
    Score: 0.175
  10. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017 06 08; 376(23):2245-2254.
    View in: PubMed
    Score: 0.173
  11. Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology. 2017 May 23; 88(21):2020-2025.
    View in: PubMed
    Score: 0.172
  12. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. 2017 Mar 06; 356:j895.
    View in: PubMed
    Score: 0.170
  13. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. Arthritis Rheumatol. 2016 05; 68(5):1183-9.
    View in: PubMed
    Score: 0.160
  14. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015 May 14; 350:h2102.
    View in: PubMed
    Score: 0.150
  15. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative. Circulation. 2021 03 09; 143(10):1002-1013.
    View in: PubMed
    Score: 0.055
  16. Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. J Clin Psychiatry. 2019 06 18; 80(4).
    View in: PubMed
    Score: 0.050
  17. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. JAMA. 2018 12 18; 320(23):2429-2437.
    View in: PubMed
    Score: 0.048
  18. Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study. Neurology. 2018 08 07; 91(6):e533-e542.
    View in: PubMed
    Score: 0.047
  19. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry. 2018 06 01; 175(6):564-574.
    View in: PubMed
    Score: 0.046
  20. Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms. Pharmacoepidemiol Drug Saf. 2019 01; 28(1):62-69.
    View in: PubMed
    Score: 0.046
  21. Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study. J Am Heart Assoc. 2018 01 24; 7(3).
    View in: PubMed
    Score: 0.045
  22. Placental Complications Associated With Psychostimulant Use in Pregnancy. Obstet Gynecol. 2017 12; 130(6):1192-1201.
    View in: PubMed
    Score: 0.045
  23. Patterns of opioid initiation at first visits for pain in United States primary care settings. Pharmacoepidemiol Drug Saf. 2018 05; 27(5):495-503.
    View in: PubMed
    Score: 0.044
  24. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States. Psychiatr Serv. 2017 Nov 01; 68(11):1112-1119.
    View in: PubMed
    Score: 0.043
  25. Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstet Gynecol. 2017 01; 129(1):174-184.
    View in: PubMed
    Score: 0.042
  26. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry. 2016 09 01; 73(9):938-46.
    View in: PubMed
    Score: 0.041
  27. Late Pregnancy ß Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics. 2016 09; 138(3).
    View in: PubMed
    Score: 0.041
  28. Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions. JAMA. 2016 Mar 15; 315(11):1164-6.
    View in: PubMed
    Score: 0.040
  29. Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures. Obstet Gynecol. 2015 Aug; 126(2):271-278.
    View in: PubMed
    Score: 0.038
  30. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015 Jun 02; 313(21):2142-51.
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.